ResearcherBaylor Scott & White Research InstituteNo recent work listed
Raju Kandimalla
Matched on ORCID iD 0000-0002-0342-5229; OpenAlex author ID A5018770643. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2020: 1 paper · 2021: none · 2022: 1 paper
Papers 2
- Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000003945↗
- A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-19-4044↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hideo Baba · 2 shared papers, 2020–2022 · strength 0.27
- Paper Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancre… DOI 10.1097/sla.0000000000003945↗
- Paper A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patient… DOI 10.1158/1078-0432.ccr-19-4044↗
- Ajay Goel · 2 shared papers, 2020–2022 · strength 0.27
- Paper Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancre… DOI 10.1097/sla.0000000000003945↗
- Paper A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patient… DOI 10.1158/1078-0432.ccr-19-4044↗
- Fuminori Sonohara · 1 shared paper, 2022 · strength 0.14
- Douglas B. Evans · 1 shared paper, 2022 · strength 0.14
- Yasuhiro Kodera · 1 shared paper, 2022 · strength 0.14
- Susan Tsai · 1 shared paper, 2022 · strength 0.14
- Song Cheol Kim · 1 shared paper, 2022 · strength 0.14
- Daniel D. Von Hoff · 1 shared paper, 2022 · strength 0.14
- Kensuke Yamamura · 1 shared paper, 2020 · strength 0.13
- Hideo Tomihara · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.